Evidence map›Paper›PMID 35900025›Full record

ArticleProtein science : a publication of the Protein Society2022

ATP-independent molecular chaperone activity generated under reducing conditions.

Axel Leppert, Gefei Chen, Danai Lianoudaki, Chloe Williams, Xueying Zhong, Jonathan D Gilthorpe, Michael Landreh, Jan Johansson

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain.Protein science : a publication of the Protein Society · 2023
    Review
  4. Amyloid inhibition by molecular chaperonesRSC medicinal chemistry · 2023
    Review
  5. Article
  6. Article
  7. ATP-independent molecular chaperone activity generated under reducing conditions.Protein science : a publication of the Protein Society · 2022
    Article
  8. OAF: a new member of the BRICHOS family.Bioinformatics advances · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Axel LeppertDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0001-6223-3350
Gefei ChenDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Danai LianoudakiDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Solna, Sweden.
Chloe WilliamsDepartment of Integrative Medical Biology, Umeå University, Umeå, Sweden.
Xueying ZhongDivision of Structural Biotechnology, Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, Huddinge, Sweden.
Jonathan D GilthorpeDepartment of Integrative Medical Biology, Umeå University, Umeå, Sweden.
Michael LandrehDepartment of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Solna, Sweden.ORCID 0000-0002-7958-4074
Jan JohanssonDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular chaperones are essential to maintain proteostasis. While the functions of intracellular molecular chaperones that oversee protein synthesis, folding and aggregation, are established, those specialized to work in the extracellular environment are less understood. Extracellular proteins reside in a considerably more oxidizing milieu than cytoplasmic proteins and are stabilized by abundant disulfide bonds. Hence, extracellular proteins are potentially destabilized and sensitive to aggregation under reducing conditions. We combine biochemical and mass spectrometry experiments and elucidate that the molecular chaperone functions of the extracellular protein domain Bri2 BRICHOS only appear under reducing conditions, through the assembly of monomers into large polydisperse oligomers by an intra- to intermolecular disulfide bond relay mechanism. Chaperone-active assemblies of the Bri2 BRICHOS domain are efficiently generated by physiological thiol-containing compounds and proteins, and appear in parallel with reduction-induced aggregation of extracellular proteins. Our results give insights into how potent chaperone activity can be generated from inactive precursors under conditions that are destabilizing to most extracellular proteins and thereby support protein stability/folding in the extracellular space. SIGNIFICANCE: Chaperones are essential to cells as they counteract toxic consequences of protein misfolding particularly under stress conditions. Our work describes a novel activation mechanism of an extracellular molecular chaperone domain, called Bri2 BRICHOS. This mechanism is based on reducing conditions that initiate small subunits to assemble into large oligomers via a disulfide relay mechanism. Activated Bri2 BRICHOS inhibits reduction-induced aggregation of extracellular proteins and could be a means to boost proteostasis in the extracellular environment upon reductive stress.

Indexed as

Molecular ChaperonesProtein FoldingAdenosine TriphosphateDisulfidesProtein DomainsAdenosine TriphosphateDisulfidesMolecular ChaperonesATP-independent molecular chaperoneBri2 BRICHOSBRICHOS domaindisulfide bond formationextracellular protein aggregation

Identifiers

PMID35900025
PMCPMC9278091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.